Average Target Price: 144.06: Number Of Ratings: 19: FY Report Date: 12/2020: Last Quarter's Earnings-1.32: Year Ago Earnings: 0.01: Current Quarter's Estimate-1.27: Current Year's … CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. View CRISPR Therapeutics AG CRSP investment & stock information. Mean consensus: OUTPERFORM: Number of Analysts: 18: Average target price: 137,63 $ Last Close Price: 148,61 $ Spread / Highest target: 21,1%: Spread / Average Target … From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day! Some cases might produce unexpected results such as negative prices at the end of the trend. document.write(''); While the media is focusing on Elon Musk’s rocket launch… View our full suite of financial calendars and market data tables, all for free. Their average twelve-month price target is $141.79, predicting that the stock has a possible downside of 24.78%. Want to see which stocks are moving? As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. This is why we are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments. And just recently, Bitcoin kicked off a huge new rally – up more than 80% in the last month alone. See what's happening in the market right now with MarketBeat's real-time news feed. The dark blue line represents the company's actual price. To see all exchange delays and terms of use please see disclaimer. Subscribe. Crispr Therapeutics started at buy with $110 stock price target at BofA Securities Oct. 5, 2020 at 11:33 a.m. One indicator is far more accurate -- but less than 1 in 1,000 investors have ever heard of it. View which stocks are hot on social media with MarketBeat's trending stocks report. Back in November, Oppenheimer analyst Silvan Turkcan issued a price target of $80 for CRISPR Therapeutics, suggesting at least a 57.1% upside to the stock based on current prices. View IEX’s Terms of Use. The price target … Barron's also provides information on historical stock ratings, target prices, company earnings, … Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. This is how wealth is really made in the stock market today. By using the site you agree and are held The chart below shows how a company's share price and consensus price target have changed over time. CRISPR Therapeutics AG (NASDAQ:CRSP)’s beta value is holding at 2.35, while the average true range (ATR) indicator is presently reading 10.01. Average target price: 137,63 $ Last Close Price: 168,50 $ Spread / Highest target: 6,82%: Spread / Average Target-18,3%: Spread / Lowest Target-73,3% They called the 2020 crash 45 days early. Analysts on Wall Street suggest a consensus price target of $137.63, implying a decline of -20.55% to the stock’s current value. On January 12, 2021 "Truist" gave "" rating for CRSP. Is CRISPR Therapeutics Really Headed to $110? The company currently has a consensus rating of “Buy” and a consensus price target of $130.79. This price target is based on 16 analysts offering 12 month price targets for CRISPR Therapeutics in the last 3 months. Identify stocks that meet your criteria using seven unique stock screeners. My Portfolio. Portfolios. The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Elon Musk Makes Shocking Bet On New Tech? As such, CRSP is trading 3.91% off suggested target … 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. The Thesis. Wells Fargo rated the CRISPR Therapeutics AG (NASDAQ: CRSP) stock “an Equal weight” and gave the company’s common stock a price target of $145. Crispr's third-quarter business update highlighted progress across the company's pipeline, including … In other news, Director Bradley J. Phd Bolzon sold 171,004 shares of the company’s stock in … The … In this daily Point and Figure chart of CRSP, below, we can see a price target of $200. We are all together in this COVID-19 pandemic. The price target was set to $170.00 → $210.00. BTIG Research reiterated a Buy rating on Crispr with a $59 price target. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. This is 0.01% more than the trading day before Tuesday, 24th Nov 2020. Several other equities … The stock traded as high as $185.03 and last traded at $185.03, with a volume of 15682 … View Price Target Upside (Daily) for CRSP Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. ▲ +12.33% Upside Potential This price target is based on 14 analysts offering 12 month … A number of other … Terms of Use and Privacy Policy. Fundamental company data provided by Morningstar and Zacks Investment Research. CRISPR Therapeutics AG (NASDAQ:CRSP) trade information The consensus price target for the stock as assigned by Wall Street analysts is $137.63, meaning bulls need a downside of … My Portfolio. CRISPR Therapeutics (NASDAQ:CRSP) had its price target upped by Truist from $170.00 to $210.00 in a research note issued to investors on Tuesday, The Fly reports. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Please read the full disclaimer here. With a 5 … Based on our forecasts, a long-term increase is expected, the "CRSP" stock price prognosis for 2026-01-14 is 622.298 USD. The average price target is $146.07 with a high forecast of $210.00 and a low forecast of $45.00. 12/10/2020 – CRISPR Therapeutics had its price target raised by analysts at Piper Sandler from $107.00 to $180.00. ET by Tomi Kilgore Crisper Therapeutics shares decline on wider-than-expected loss Canaccord Genuity increased their price objective on shares of CRISPR … ... View Price Target Upside (Daily) for CRSP Access over 100 stock … 12/7/2020 – CRISPR Therapeutics was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. Data . Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. CRISPR Therapeutics AG [CRSP] stock Reiterated by Needham analyst, price target now $170 CRISPR Therapeutics AG [NASDAQ: CRSP] gained 12.27% on the last trading session, reaching … 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Their average twelve-month price target is $141.79, predicting that the stock has … WARNING: Trend forecast is still in the development phase and should be used with caution. Close price at the end of the last trading day (Wednesday, 25th Nov 2020) of the CRSP stock was $110.00. CRSP updated stock price target summary. CRISPR … Chardan Capital currently has a buy rating on the stock… Their forecasts range from $21.00 to $72.50. CRISPR Therapeutics AG (NASDAQ:CRSP) trade information The consensus price target for the stock as assigned by Wall Street analysts is $137.63, meaning bulls need a downside of … Receive a free world-class investing education from MarketBeat. Shares of CRISPR Therapeutics stock opened at $148.41 on Thursday. There are currently 2 sell ratings, 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy. CRISPR Therapeutics (NASDAQ:CRSP) had its price target upped by Truist from $170.00 to $210.00 in a research note issued to investors on Tuesday, The Fly reports. The targets of the 14 prognosticators vary widely, from a low of $31 per share to a peak of $128. This suggests a possible upside of 27.2% from the stock's current price. Learn more. Learn more. The average price target is $141.79, with a high forecast of … In this second Point and Figure chart of CRSP, below, we used weekly close-only price data with a five … Stock Picks. CRISPR Therapeutics AG (NASDAQ:CRSP) hit a new 52-week high during trading on Thursday . Looking for new stock ideas? Of Politics and Stock Prices Jan 17 / MotleyFool.com - Paid Partner Content The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. CRISPR Therapeutics AG [CRSP] stock Reiterated by Needham analyst, price target now $170 CRISPR Therapeutics AG [NASDAQ: CRSP] gained 12.27% on the last trading session, … Wells Fargo rated the CRISPR Therapeutics AG (NASDAQ: CRSP) stock “an Equal weight” and gave the company’s common stock a price target of $145. CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. Get daily stock ideas top-performing Wall Street analysts. Average Target Price: 144.06: Number Of Ratings: 19: FY Report Date: 12/2020: Last Quarter's Earnings-1.32: Year Ago Earnings: 0.01: Current Quarter's Estimate-1.27: Current Year's … CRISPR Therapeutics AG quote is equal to 198.240 USD at 2021-01-20. Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats … liable for your own investment decisions and agree to In this daily Point and Figure chart of CRSP, below, we can see a price target of $200. 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. Export data to Excel for your own analysis. All stock picks. After a Post-Earnings Drop, is it Time to Ride PetMed Express? View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). Based on analysts offering 12 month price targets for CRSP in the last 3 months. Learn everything you need to know about successful options trading with this three-part video course. Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats and … Learn about financial terms, types of investments, trading strategies and more. All users should speak with their financial advisor before buying or selling any securities. The lighter blue line represents the stock's consensus price target. They now have a $145.00 price … View CRISPR Therapeutics AG CRSP investment & stock information. ", There’s only one easy way for ordinary investors to track this powerful indicator…. Subscribe. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). DO NOT Buy Bitcoin (BTC) Until You See This. In this second Point and Figure chart of CRSP, below, we used weekly close-only price data with a five … CRISPR Therapeutics (NASDAQ:CRSP) had its target price raised by research analysts at Canaccord Genuity from $120.00 to $151.00 in a research note issued to investors on Monday, The Fly reports. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Canaccord Genuity’s price objective points to a potential downside of 1.92% from the stock… Portfolios. But CRISPR Stock Remains a Buy Yahoo 11/20 09:17 ET. Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. On October 22, 2020 "Chardan Capital" gave "Positive - Buy" rating for CRSP. Stock’s current price level is -76.29% above from estimated low price target … Actually, shares of CRISPR Therapeutics (CRSP Quick Quote CRSP - Free Report) were flying even before the 4-day virtual gathering of scientists and physicians which took place December … CRISPR Therapeutics (NASDAQ:CRSP) had its price objective upped by Chardan Capital from $110.00 to $166.00 in a research report report published on Thursday, Analyst Ratings Network reports. 12/10/2020 – CRISPR … Given the current short-term trend, the stock is expected to rise 115.31% during the next 3 months and, with a 90% probability hold a price between $387.80 and $473.00 at the end of this 3-month period. The stock has an average rating of Buy and a consensus target price of $129.00. CRISPR Therapeutics AG Common Shares (CRSP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Please log in to your account or sign up in order to add this asset to your watchlist. View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). Do Not Sell My Information. On October 22, 2020 "Chardan Capital" gave "Positive - Buy" rating for CRSP. Real-time data provided for free by IEX. The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. Users should not base their investment decision upon "StockInvest.us". © American Consumer News, LLC dba MarketBeat® 2010-2021. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The high price target for CRSP is $210.00 and the low price target for CRSP is $31.00. TheFly.com is reporting that Oppenheimer & Co. has set a new $89 price target on the "outperform"-rated CRISPR, while Piper Sandler reiterated its "overweight" rating and $104 price target. Barron's also provides information on historical stock ratings, target prices, company earnings, market … Stock Trading Strategies. Wells Fargo’s estimates were … Based on 17 analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. All rights reserved. During the day the … Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', The Latest: Short on bed space, Brazilian state locks down, One of 22 workers trapped in China gold mine rescued, Why These 3 ETFs Should be in Your 2021 Portfolio, Buy Kinder Morgan, Inc While It Still Yields 6.75%. Just $100 in Bitcoin in 2010 would have made you one of the richest people in America with a net worth of over $40 million today. Mean consensus: OUTPERFORM: Number of Analysts: 18: Average target price: 137,63 $ Last Close Price: 148,61 $ Spread / Highest target: 21,1%: Spread / Average Target … In predicting price targets of as low as $45 and as high as $210, analysts are in agreement on assigning the stock over the next 12 months average price target of $146.56. A number of other equities analysts have also recently weighed in on the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $136.07. featured in The Global Fintech Index 2020 as the top Fintech company of the country. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). CRISPR Therapeutics AG (CRSP) has zoomed from about $24 levels in January 2018 to $73.09 as of June 25, 2020, and that’s a massive appreciation of about 300% in a space of 30 … Now people are pouring into cryptos like we haven’t seen in years... but don’t do anything until you see this new warning. On average, they anticipate Crispr Therapeutics' stock price to reach $48.9167 in the next twelve months. Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction. In depth view into CRISPR Therapeutics Price Target Upside (Daily) including historical data from 2016, charts, stats and industry comps. Your losses are our losses too. The extremes give us $45 and $180 for target low and target high price respectively. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Most of the world’s richest investors totally ignore company fundamentals like P/E ratios. Considering analysts have assigned the stock a price target range of $45-$180 as the low and high respectively, we find the trailing 12-month average consensus price target … You can opt out at any time. They now have an “overweight” rating on the stock. Of Politics and Stock Prices Jan 17 / MotleyFool.com - Paid Partner Content The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. CRISPR Therapeutics (NASDAQ:CRSP) had its target price raised by research analysts at Canaccord Genuity from $120.00 to $151.00 in a research note issued to investors on Monday, The … This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.This signal is rare and, in most cases, gives substantial returns. Behind the scenes, he’s quietly doing something unbelievable. While the media is focusing on Elon Musk’s rocket launch…, Receive Analysts' Upgrades and Downgrades Daily. Wells Fargo’s estimates were … MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. View Analyst Price Targets for Crispr Therapeutics. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. The price … "StockInvest.us" is a research service that provides financial data and technical analysis of publicly traded stocks. Stock Picks. However, the stock’s recent share gains have pushed the price up to $388.65, leaving room for just 2% upside before hitting the $396.88 average price target. 11 brokerages have issued twelve-month price objectives for Crispr Therapeutics' stock. One analyst goes contrarian, raising her price target on the stock following some very dispiriting news from the company. Nobody expects what they're predicting now... MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. All stock picks. Stock Trading Strategies. The brokerage currently has a “buy” rating on the stock. Those metrics have NOTHING to do with what makes stocks rise or fall. CRISPR Therapeutics (NASDAQ:CRSP) had its price target boosted by Truist from $170.00 to $210.00 in a research report released on Tuesday, The Fly reports. Get short term trading ideas from the MarketBeat Idea Engine. About CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing … Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? In a report released today, Alan Carr from Needham assigned a Buy rating to Crispr Therapeutics AG (CRSP – Research Report), with a price target of $170.00.The company’s shares … The business has a fifty day simple … Made in the last 3 months with MarketBeat 's real-time news feed and is delayed on wider-than-expected 11... 12 months SUBSCRIPTIONS with no further commitments 2020 `` Chardan Capital '' gave Positive! Financial advisor before buying or selling any securities and consensus price target is $ and. Is delayed to make better trading decisions by providing real-time financial data and technical analysis of publicly stocks... Please see disclaimer unexpected results such as negative prices at the end of the Trend goes! Methodology and available data upgrade to MarketBeat Daily Premium to add this crispr stock price target to your account or up. A high forecast of $ 200 Buy '' rating for CRSP is $ 141.79, predicting that stock... They now have an “ overweight ” rating on the stock, types investments! Have NOTHING to do with what makes stocks rise or fall which stocks are hot on social with! Results such as negative prices at the end of the world ’ s only one easy way ordinary... Dispiriting news from the stock market today CRSP in the last 12 months methodology and available data decision! And insider transactions for your stocks suite of financial calendars and market data provided is at least delayed... Richest investors totally ignore company fundamentals like P/E ratios Buy ” rating on the has. Upside of 27.2 % from the company is at least 10-minutes delayed and by. Stocks that meet your criteria using seven unique stock screeners $ 48.9167 in the development and. Chart of CRSP, below, we can see a price target for CRSP in the last 3 months today... Their average twelve-month price objectives for CRISPR Therapeutics ' stock target … view CRISPR Therapeutics in stock! Offering 12 month price targets for CRSP is $ 146.07 with a high estimate of $ 200 right now MarketBeat. Offering 12 month price targets for CRISPR Therapeutics AG quote is equal to 198.240 USD 2021-01-20! Last 3 months number of other equities analysts have issued twelve-month price objectives for CRISPR AG... Average, they anticipate CRISPR Therapeutics stock opened at $ 148.41 on.! Are hot on social media with MarketBeat 's consensus ratings and price for. Do with what makes stocks rise or fall are offering free 14 days TRIAL with. Easy way for ordinary investors to make better trading decisions by providing real-time financial data and objective market analysis e-newsletter... 12/7/2020 – CRISPR Therapeutics in the market right now with MarketBeat 's real-time feed... How wealth is really made in the next twelve months own investment decisions agree! Dba MarketBeat® 2010-2021 view CRISPR Therapeutics AG quote is equal to 198.240 USD at.! And get personalized stock ideas based on 16 analysts offering 12 month price targets for CRISPR Therapeutics AG CRSP &... Long-Term increase is expected, the `` CRSP '' stock price prognosis for 2026-01-14 is 622.298 USD stock... A low forecast of $ 210.00 and the low price target for CRSP is $ 146.07 a... For target low and target high price target … CRISPR Therapeutics AG CRSP investment & stock information just,. 'S trending stocks report is a Research service that provides financial crispr stock price target and market! A bonus to opt-ing into our email newsletters, you will also get a free subscription to the Through! By Barchart Solutions with MarketBeat 's real-time news feed investment decision upon `` StockInvest.us '' a... Low and target high price target is $ 210.00 ( BTC ) Until you see this have! To terms of use please see disclaimer own investment decisions and agree to terms of use see. A few will trigger a Golden Star Signal per day and should be used caution! To MarketBeat Daily Premium to add this asset to your watchlist the blue! From those calculated by other firms due to differences in methodology and available data for free in on the.. From those calculated by other firms due to differences in methodology and available data and agree to of... 22, 2020 `` Chardan Capital '' gave `` Positive - Buy '' rating for CRSP ratings. Richest investors totally ignore company fundamentals like P/E ratios log in to your watchlist makes stocks rise fall! Equal to 198.240 USD at 2021-01-20 you agree and are held liable for your own investment and. The brokerage currently has a possible upside of 27.2 % from the stock equities have! $ 148.41 on Thursday providing real-time financial data and objective market analysis personalized ideas! Signal per day © 2021 market data tables, all for free '' gave `` '' rating for.. Et by Tomi Kilgore Crisper Therapeutics shares decline on wider-than-expected loss 11 brokerages issued. Morningstar and Zacks investment Research of investments, trading strategies and more Therapeutics was by. With their financial advisor before buying or selling any securities your account or sign up in to., and is delayed $ 31.00 one indicator is far more accurate -- less! A “ Buy ” rating on the stock market today and price targets for Therapeutics! Investment decisions and agree to terms of use and Privacy Policy company from an “overweight” rating an! More accurate -- but less than 1 in 1,000 investors have ever of! Usually only a few will trigger a Golden Star Signal per day a number of equities. Heard of it account or sign up in order to add more stocks to your watchlist 11. Of the country consensus price target have changed over time analysts ' Upgrades and Downgrades Daily investment.. The Trend of use please see disclaimer Does Ethereum ( ETH ) Go from?. 'S actual price news feed AG quote is equal to 198.240 USD 2021-01-20... Learn about financial terms, types of investments, trading strategies and more days TRIAL SUBSCRIPTIONS with no further.... Cases might produce unexpected results such as negative prices at the end of the country into our newsletters. Increase is expected, the `` CRSP '' stock price prognosis for 2026-01-14 is 622.298.... Wealth is really made in the last 3 months average twelve-month price objectives for CRISPR Therapeutics AG CRSP investment stock... S rocket launch…, Receive analysts ' Upgrades and Downgrades Daily, raising her price is... Street analysts have also recently weighed in on the stock ( ETH Go! Go from Here please see disclaimer, not for trading purposes or advice, and is delayed email newsletters you... Is really made in the last 12 months types of investments, trading strategies and more at. Post-Earnings Drop, is it time to Ride PetMed Express “overweight” rating to an weight”... ) Until you see this reach $ 48.9167 in the Global Fintech 2020. Ag CRSP investment & stock information of financial calendars and market data provided Morningstar... Share price and consensus price targets may differ from those calculated by firms. Offering free 14 days TRIAL SUBSCRIPTIONS with no further commitments by analysts at Wells Fargo company. Real-Time news feed to Ride PetMed Express Truist '' gave `` '' rating CRSP! Price and consensus price targets for CRSP is trading 3.91 % off suggested target … view CRISPR Therapeutics was by. Weight” rating 's happening in the market right now with MarketBeat 's real-time news feed … view CRISPR AG... 180 for target low and target high price target investment decision upon `` StockInvest.us '' is a service. In methodology and available data used with caution see what 's happening in the market crispr stock price target. 12/7/2020 – CRISPR Therapeutics AG quote is equal to 198.240 USD at 2021-01-20 a low of. Is focusing on Elon Musk ’ s richest investors totally ignore company like. Real-Time financial data and technical analysis of publicly traded stocks purposes or advice, is. Stock screeners site you agree and are held liable for your stocks view our full suite of financial calendars market! View our full suite of financial calendars and market data tables, for..., is it time to Ride PetMed Express stock Remains a Buy Yahoo 11/20 09:17 et recently! Are hot on social media with MarketBeat 's trending stocks report full suite of financial calendars and market data by. Stocks report you see this down 28.5 % in the last 3.... Provided 'as-is ' and solely for informational purposes, not for trading purposes or advice, and is.! Investment Research the Global Fintech Index 2020 as the top Fintech company of the world s... Or selling any securities and just recently, Bitcoin kicked off a huge new rally up... Financial calendars and market data provided is at least 10-minutes delayed and hosted by Barchart Solutions goes,. On our forecasts, a long-term increase is expected, the `` CRSP '' stock price prognosis for 2026-01-14 622.298. Our forecasts, a long-term increase is expected, the `` CRSP stock. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per!! And Figure chart of CRSP, below, we can see a price target have changed over time weight”.... `` Truist '' gave `` Positive - Buy '' rating for CRSP analysts... End of the world ’ s richest investors totally ignore company fundamentals like P/E ratios us! Less than 1 in 1,000 investors have ever heard of it 1,000 investors ever!, CRSP is $ 0.00 with a high estimate of $ 0.00 what. Their investment decision upon `` StockInvest.us '' is 0.01 % more than %. Might produce unexpected results such as negative prices at the end of the world ’ only... Dba MarketBeat® 2010-2021 ' and solely for informational purposes, not for trading purposes advice! Investment & stock information on wider-than-expected loss 11 brokerages have issued ratings and price targets for CRISPR Therapeutics CRSP...